TR Biofab (Korea) Performance
| 246710 Stock | KRW 3,650 35.00 0.95% |
The entity owns a Beta (Systematic Risk) of 0.71, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, TR Biofab's returns are expected to increase less than the market. However, during the bear market, the loss of holding TR Biofab is expected to be smaller as well. At this point, TR Biofab has a negative expected return of -0.75%. Please make sure to validate TR Biofab's market risk adjusted performance, coefficient of variation, jensen alpha, as well as the relationship between the mean deviation and standard deviation , to decide if TR Biofab performance from the past will be repeated at some future date.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days TR Biofab Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Total Cashflows From Investing Activities | -33.8 B |
246710 |
TR Biofab Relative Risk vs. Return Landscape
If you would invest 589,000 in TR Biofab Co on November 27, 2024 and sell it today you would lose (224,000) from holding TR Biofab Co or give up 38.03% of portfolio value over 90 days. TR Biofab Co is generating negative expected returns and assumes 4.1282% volatility on return distribution over the 90 days horizon. Simply put, 36% of stocks are less volatile than 246710, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
TR Biofab Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for TR Biofab's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as TR Biofab Co, and traders can use it to determine the average amount a TR Biofab's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1808
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 246710 |
Estimated Market Risk
| 4.13 actual daily | 36 64% of assets are more volatile |
Expected Return
| -0.75 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.18 actual daily | 0 Most of other assets perform better |
Based on monthly moving average TR Biofab is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of TR Biofab by adding TR Biofab to a well-diversified portfolio.
TR Biofab Fundamentals Growth
246710 Stock prices reflect investors' perceptions of the future prospects and financial health of TR Biofab, and TR Biofab fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on 246710 Stock performance.
| Return On Equity | -36.36 | |||
| Return On Asset | -0.098 | |||
| Profit Margin | (0.85) % | |||
| Operating Margin | (0.86) % | |||
| Current Valuation | 534.22 B | |||
| Shares Outstanding | 8.34 M | |||
| Price To Sales | 70.20 X | |||
| Revenue | 3.23 B | |||
| EBITDA | (4.53 B) | |||
| Cash And Equivalents | 23.66 B | |||
| Total Debt | 29.81 B | |||
| Debt To Equity | 0.03 % | |||
| Cash Flow From Operations | (7.56 B) | |||
| Total Asset | 82.23 B | |||
About TR Biofab Performance
By analyzing TR Biofab's fundamental ratios, stakeholders can gain valuable insights into TR Biofab's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if TR Biofab has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if TR Biofab has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
TR Biofab Co., Ltd. researches and develops medical devices for transplantation and tissue regeneration in the areas of orthopedics, plastic surgery, and dentistry. The company was founded in 2013 and is based in Siheung, South Korea. TR Biofab is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about TR Biofab performance evaluation
Checking the ongoing alerts about TR Biofab for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for TR Biofab help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| TR Biofab generated a negative expected return over the last 90 days | |
| TR Biofab has high historical volatility and very poor performance | |
| The company reported the revenue of 3.23 B. Net Loss for the year was (11.08 B) with profit before overhead, payroll, taxes, and interest of 2.64 B. | |
| TR Biofab Co has accumulated about 23.66 B in cash with (7.56 B) of positive cash flow from operations. | |
| Roughly 32.0% of the company shares are owned by insiders or employees |
- Analyzing TR Biofab's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether TR Biofab's stock is overvalued or undervalued compared to its peers.
- Examining TR Biofab's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating TR Biofab's management team can have a significant impact on its success or failure. Reviewing the track record and experience of TR Biofab's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of TR Biofab's stock. These opinions can provide insight into TR Biofab's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for 246710 Stock analysis
When running TR Biofab's price analysis, check to measure TR Biofab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TR Biofab is operating at the current time. Most of TR Biofab's value examination focuses on studying past and present price action to predict the probability of TR Biofab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TR Biofab's price. Additionally, you may evaluate how the addition of TR Biofab to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges |